SCHEMBL3543229

SCHEMBL3543229

O=S(=O)(Cl)c1nccc2oncc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2996456 0.83 COMT (0.32)
SCHEMBL17537339 0.72 CYP2A6 (0.45)
SCHEMBL29954559 0.69 CCR1 (0.34)
SCHEMBL1052021 0.66 CYP2A6 (0.52)
SCHEMBL29797287 0.66 CYP2A6 (0.52)
Hydrochloric Acid SCHEMBL7319620 0.64 CYP2A6 (0.50)
SCHEMBL30665364 0.61 TRPV4 (0.42)
SCHEMBL30952445 0.60 TRPM5 (0.39)
Benzo[D]Isoxazole SCHEMBL5773956 0.58 TDP1 (0.35)
SCHEMBL2042500 0.58 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713964-B2 Methods for treating asthmatic conditions WYETH LLC (US) 2010-05-11 US disclosed
US-7605156-B2 Methods for the use of inhibitors of cytosolic phospholipase A2 WYETH (US) 2009-10-20 US disclosed